Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Syngene International Ltd. ( (IN:SYNGENE) ) has shared an update.
Syngene International Ltd. has notified the stock exchanges that the transcript of its Q3 FY2026 earnings call, held on January 23, 2026, has been uploaded to the company’s website in compliance with SEBI’s disclosure regulations. The move enhances transparency for investors and analysts by providing detailed access to management’s commentary on quarterly performance and outlook, reinforcing the company’s ongoing adherence to corporate governance and disclosure norms.
More about Syngene International Ltd.
Syngene International Ltd., headquartered in Bengaluru, operates in the contract research, development and manufacturing (CRDMO) space, providing integrated scientific services to global pharmaceutical, biotechnology and other life sciences companies.
Average Trading Volume: 59,430
Technical Sentiment Signal: Sell
Current Market Cap: 196.9B INR
For detailed information about SYNGENE stock, go to TipRanks’ Stock Analysis page.